Cerebroprotective Mechanism of Qizhi Formula in Ameliorating Cerebral Ischemia-Reperfusion Injury
刊名 Medicinal Plant
作者 Hanrui BAI, Chunhui LIU, Yanbin LI, Lifen WANG, Zeyu WU, Qin WANG, Wenling CONG, Jiawei LIU
作者单位 College of Traditional Chinese Medicine, Inner Mongolia Medical University, Jinshan Economic and Technological Development Zone
DOI DOI:10.19600/j.cnki.issn2152-3924.2026.05.013
年份 2026
刊期 5
页码 73-77
关键词 Cerebral ischemia-reperfusion injury (CIRI), Qizhi Formula, Microglial polarization, Wnt/β-catenin signaling pathway, Neuroinflammation
摘要 [Objectives] To investigate the cerebroprotective mechanisms of Qizhi Formula against cerebral ischemia-reperfusion injury (CIRI) through in vitro cellular experiments. [Methods] The injury model of BV2 microglia induced by oxygen-glucose deprivation/reoxygenation (OGD/R) was established. The reliability of the model was validated through cell counting kit-8 (CCK-8) and lactate dehydrogenase (LDH) release assays. Successfully modeled BV2 cells were subsequently allocated into six groups: blank, model, nimodipine, Astragali Radix, Hirudo, and Qizhi Formula groups, with corresponding drug-containing sera prepared for each. Enzyme-linked immunosorbent assay (ELISA) was employed to quantify the levels of pro-inflammatory cytokines (TNF-α, IL-1β) and anti-inflammatory cytokines (IL-10, TGF-β) in the cell culture supernatants. Real-time quantitative polymerase chain reaction (RT-qPCR) was conducted to assess the mRNA expression of M1 microglial markers (CD86, iNOS) and M2 microglial markers (CD206, Arg1) across the different groups. [Results] ELISA results showed that, compared to the blank control group, the model group exhibited a significant increase in pro-inflammatory factor levels alongside a decrease in anti-inflammatory factors. In comparison to the model group, treatment with drug-containing serum from all drug intervention groups significantly downregulated the expression of TNF-α and IL-1β, while upregulating IL-10 and TGF-β levels in OGD/R-injured BV2 cells (P<0.01). Furthermore, Qizhi Formula produced superior effects relative to single treatments with Astragali Radix or Hirudo (P<0.05). RT-qPCR analysis revealed that OGD/R stimulation significantly increased the mRNA expression of M1 markers CD86 and iNOS in BV2 cells. Treatment with nimodipine and Qizhi Formula markedly inhibited the upregulation of these M1 markers (P<0.01) while concurrently enhancing the mRNA expression of M2 markers CD206 and Arg1 (P<0.01). [Conclusions] Qizhi Formula provides cerebroprotection against CIRI by regulating the M1/M2 polarization balance of BV2 microglia and attenuating excessive neuroinflammatory responses, thereby offering pharmacological evidence supporting the use of this formula.